Novalis Biotech
Overview
An early-stage venture capital firm specializing in life sciences, focusing on enabling technologies. Novalis Biotech invests in innovative research and manufacturing tools, bioinformatics, genomics, diagnostics, and digital health, supporting early-stage startups from pre-seed to Series A. The firm emphasizes capital-light platform technologies and close interaction with customers from the early stages of a company's life, aiming to create value for stakeholders by providing funding, leveraging professional and academic connections, and shaping business strategies.
Investment Focus
- Innovative concepts in healthcare
- Capital-light business models
- Platform technologies in life sciences
Portfolio Companies
Get the full list of 54,000+ investors
Novalis Biotech and every other firm and angel in the database — as one spreadsheet you keep.
$19one-time payment · no subscription- All 54,000+ investors — VC firms, private equity, family offices and angels
- The key person to contact at each one, with their job title
- Their work email address
- Their phone number
- Their LinkedIn profile
- Delivered as a single .xlsx file — download it as many times as you like
Every profile on this site is one row of the file, with the contact details masked — browse a few before you buy.
Frequently asked questions about Novalis Biotech
What sectors does Novalis Biotech invest in?
Novalis Biotech invests in Technology, Health, Medical Devices, Biotechnology and Nanotechnology, and is based in Gent, Belgium. Novalis Biotech is listed as a venture capital in the ConnectSafely investor database.
What stage does Novalis Biotech invest at?
Novalis Biotech backs companies at Pre-Seed, Seed, Early Stage and Series A, writing cheques of 50K - 4M.
Which regions does Novalis Biotech invest in?
Novalis Biotech invests across United States, United Kingdom, Germany, France, Italy and Denmark.
Who are the partners at Novalis Biotech?
Team members listed for Novalis Biotech include Bart Rossel (Partner & Advisor).
What companies has Novalis Biotech invested in?
Novalis Biotech's portfolio includes Alithea Genomics, Enzyre, BioLizard, Cergentis, Epify, Fertiga, myNEO and OHMX.bio.
How do I contact Novalis Biotech?
Novalis Biotech's contact details — including LinkedIn — are listed in the ConnectSafely investor database, along with its website and the LinkedIn profiles of its partners.
Last updated · Source: ConnectSafely investor database
